F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma

Liu,Yiyan

doi:10.3892/mco.2017.1458

F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma

Authors:
- Yiyan Liu
View Affiliations

Affiliations: Department of Radiology, Nuclear Medicine Section, Rutgers New Jersey Medical School, University Hospital, Newark, NJ 07103, USA
Published online on: October 18, 2017 https://doi.org/10.3892/mco.2017.1458
Pages: 1147-1151

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bone hemangiopericytoma (HPC) is extremely rare, and its clinical manifestations and radiographic features are nonspecific. There are few case reports about application of F18‑fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HPC. A total of four subjects with pathologically diagnosed bone HPC had FDG PET/CT for staging and/or restaging bone HPC. Medical records were retrospectively reviewed for radiological, pathological and follow‑up information. All primary bone and metastatic lesions demonstrated high FDG avidity on PET/CT, which also revealed the adjacent soft tissue involvement and synchronous lesion. PET/CT correctly detected metastatic lesions in 1 patient. Furthermore, 3/4 patients with available laboratory data had hypocalcemia, but normal phosphorus levels when HPC existed as primary lesions or metastatic disease; however, normalization of calcium levels when they were disease‑free. The results suggested that FDG PET/CT could be effectively used for staging, surveillance and detection of recurrent/metastatic disease in HPC. There may be an association between bone HPC and hypocalcemia.

View Figures

View References

1	Stout AP and Murray MR: Hemangiopericytoma: A vascular tumor featuring zimmermann's pericytes. Ann Surg. 116:26–33. 1942. View Article : Google Scholar : PubMed/NCBI
2	Verbeke SL and Bovée JV: Primary vascular tumors of bone: A spectrum of entities? Int J Clin Exp Pathol. 4:541–551. 2011.PubMed/NCBI
3	Fletcher CD: The evolving classification of soft tissue tumours: An update based on the new who classification. Histopathology. 48:3–12. 2006. View Article : Google Scholar : PubMed/NCBI
4	Gengler C and Guillou L: Solitary fibrous tumour and haemangiopericytoma: Evolution of a concept. Histopathology. 48:63–74. 2006. View Article : Google Scholar : PubMed/NCBI
5	Espat NJ, Lewis JJ, Leung D, Woodruff JM, Antonescu CR, Shia J and Brennan MF: Conventional hemangiopericytoma: Modern analysis of outcome. Cancer. 95:1746–1751. 2002. View Article : Google Scholar : PubMed/NCBI
6	Combs SE, Thilmann C, Debus J and Schulz-Ertner D: Precision radiotherapy for hemangiopericytomas of the central nervous system. Cancer. 104:2457–2465. 2005. View Article : Google Scholar : PubMed/NCBI
7	Unni KK, Ivins JC, Beabout JW and Dahlin DC: Hemangioma, hemangiopericytoma and hemangioendothelioma (angiosarcoma) of bone. Cancer. 27:1403–1414. 1971. View Article : Google Scholar : PubMed/NCBI
8	Liu J, Cao L, Liu L, Guo S, Tai H and Chen Z: Primary epidural hemangiopericytoma in the sacrum: A rare case and literature review. Tumour Biol. 35:11655–11658. 2014. View Article : Google Scholar : PubMed/NCBI
9	Zhang P, Hu J and Zhou D: Hemangiopericytoma of the cervicothoracic spine: A case report and literature review. Turk Neurosurg. 24:948–953. 2014.PubMed/NCBI
10	Lian YW, Yao MS, Hsieh SC, Lao WT, Fang CL and Chan WP: MRI of hemangiopericytoma in the sacrum. Skeletal Radiol. 33:485–487. 2004. View Article : Google Scholar : PubMed/NCBI
11	Dürr HR, Nerlich A, Lienemann A, Müller PE and Refior HJ: Malignant hemangiopericytoma of the bone. Langenbecks Arch Surg. 385:207–212. 2000. View Article : Google Scholar : PubMed/NCBI
12	Sahin-Akyar G, Fitöz S, Akpolat I, Sağlik Y and Erekul S: Primary hemangiopericytoma of bone located in the tibia. Skeletal Radiol. 26:47–50. 1997. View Article : Google Scholar : PubMed/NCBI
13	Lin YJ, Tu YK, Lin SM and Shun CT: Primary hemangiopericytoma in the axis bone: Case report and review of literature. Neurosurgery. 39:397–399. 1996. View Article : Google Scholar : PubMed/NCBI
14	Tang JS, Gold RH, Mirra JM and Eckardt J: Hemangiopericytoma of bone. Cancer. 62:848–859. 1988. View Article : Google Scholar : PubMed/NCBI
15	Jain AS, Shelley S, Muthukrishnan I, Kalal S, Amalachandran J and Chandran S: Diagnostic importance of contrast enhanced (18)F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience. Indian J Nucl Med. 31:14–19. 2016. View Article : Google Scholar : PubMed/NCBI
16	Lee SJ, Kim ST, Park SH, Choi YL, Park JB, Kim SJ and Lee J: Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma. Clin Sarcoma Res. 4:132014. View Article : Google Scholar : PubMed/NCBI
17	Aras M, Dede F, Ones T, Atasoy BM, Inanir S, Erdil TY and Turoglu HT: F-18 FDG PET/CT findings of primary sinonasal hemangiopericytoma: Rare location in a young adult patient. Clin Nucl Med. 36:473–474. 2011. View Article : Google Scholar : PubMed/NCBI
18	Ito S, Yokoyama J, Yoshimoto H, Yazawa M, Kazuo K, Hanaguri M, Ohba S, Fujimaki M and Ikeda K: Usefulness of choline-PET for the detection of residual hemangiopericytoma in the skull base: Comparison with FDG-PET. Head Face Med. 8:32012. View Article : Google Scholar : PubMed/NCBI
19	Hung TJ, Macdonald W, Muir T, Celliers L and Al-Ogaili Z: 68Ga DOTATATE PET/CT of Non-FDG-Avid pulmonary metastatic hemangiopericytoma. Clin Nucl Med. 41:779–780. 2016. View Article : Google Scholar : PubMed/NCBI
20	Khadgawat R, Singh Y, Kansara S, Tandon N, Bal C, Seith A and Kotwal P: PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia. Singapore Med J. 50:e55–e57. 2009.PubMed/NCBI
21	Verbeke SL, Fletcher CD, Alberghini M, Daugaard S, Flanagan AM, Parratt T, Kroon HM, Hogendoorn PC and Bovée JV: A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone. Am J Surg Pathol. 34:777–783. 2010. View Article : Google Scholar : PubMed/NCBI
22	Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, Fernandez W, Gabler F, Gonzales G and Reginato AJ: Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol. 9:373–379. 2003. View Article : Google Scholar : PubMed/NCBI
23	Chung J and Henry RR: Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma. J Clin Endocrinol Metab. 81:919–925. 1996. View Article : Google Scholar : PubMed/NCBI